These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 72604)

  • 41. Solid tumor chemotherapy: new drugs and horizons.
    Yardumian H
    J Am Osteopath Assoc; 1974 Dec; 74(4):299-306. PubMed ID: 4140203
    [No Abstract]   [Full Text] [Related]  

  • 42. Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Engstrom PF; Catalano RB; Creech RH
    Cancer Treat Rep; 1976 Mar; 60(3):285-7. PubMed ID: 1260784
    [No Abstract]   [Full Text] [Related]  

  • 43. Sequential combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Lester EP; Kinnealey A; Matz GJ
    Laryngoscope; 1979 Dec; 89(12):1921-9. PubMed ID: 92740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A reserve chemotherapy for Hodgkin's disease (author's transl)].
    Amiel JL; Ayed FB; Droz JP; Tursz T; Brule CH
    Nouv Presse Med; 1980 Oct; 9(37):2705-6. PubMed ID: 6159573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CCNU and bleomycin in the treatment of cancer: a Southwest Oncology Group Study.
    Hoogstraten B; Haas CD; Haut A; Talley RW; Rivkin S; Isaacs BL
    Med Pediatr Oncol; 1975; 1(2):95-106. PubMed ID: 59307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
    Bruckner HW; Deppe G
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
    Cedermark BJ; Didolkar MS; Elias EG
    Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.
    Creagan ET; Hahn RG; Ahmann DL; Edmonson JH; Bisel HF; Eagan RT
    Cancer Treat Rep; 1976 Sep; 60(9):1385-7. PubMed ID: 189922
    [No Abstract]   [Full Text] [Related]  

  • 50. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
    Takita H; Brugarolas A; Mittelman A; Vincent R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
    [No Abstract]   [Full Text] [Related]  

  • 51. Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones".
    Moertel CG; Engstrom P; Lavin PT; Gelber RD; Carbone PP
    Surgery; 1979 May; 85(5):509-13. PubMed ID: 155322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapy of inoperable bronchial carcinoma].
    Kokron O; Cerni C; Micksche M; Titscher R; Wrba H
    Osterr Z Onkol; 1977 Nov; 4(5-6):106-10. PubMed ID: 202906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
    Abele R; Bernheim J; Cumps E; Buyse M; Kenis Y
    Cancer Treat Rep; 1981; 65(5-6):505-6. PubMed ID: 6165474
    [No Abstract]   [Full Text] [Related]  

  • 54. [Chemotherapy of renal cell carcinoma. 2. Single-agent therapy with CCNU].
    Satomi Y; Takai S; Nakahashi M
    Nihon Hinyokika Gakkai Zasshi; 1982 Nov; 73(11):1431-5. PubMed ID: 7154472
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma.
    Johnson DE; Chalbaud RA; Holoye PY; Samuels ML
    Cancer Chemother Rep; 1975; 59(2 Pt 1):433-5. PubMed ID: 50126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A trial of bleomycin versus adriamycin in advanced carcinoma of the bladder.
    Turner AG; Durrant KR; Malpas JS
    Br J Urol; 1979 Apr; 51(2):121-4. PubMed ID: 88987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of brain extension in small-cell carcinoma of the bronchus.
    Williams CJ
    Med Pediatr Oncol; 1978; 4(4):305-10. PubMed ID: 214691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New chemotherapeutic agents--bleomycin and adriamycin.
    Carter SK; Blum RH
    CA Cancer J Clin; 1974; 24(6):322-31. PubMed ID: 4140753
    [No Abstract]   [Full Text] [Related]  

  • 59. Adjunctive management of thyroid cancer: chemotherapy.
    Shimaoka K
    J Surg Oncol; 1980; 15(3):283-6. PubMed ID: 6159502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adriamycin-vitamin E combination therapy for treatment of prostate adenocarcinoma in the Nb rat model.
    Nesbitt JA; Smith J; McDowell G; Drago JR
    J Surg Oncol; 1988 Aug; 38(4):283-4. PubMed ID: 3411971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.